NAFDAC Gives Approval to AstraZeneca Vaccine for Use

The National Agency for Food and Drug Administration and Control, NAFDAC has given approval to Oxford/AstraZeneca vaccine for use in the country.

NAFDAC Director-General, Dr. Mojisola Adeyeye made the disclosure while briefing journalists on Thursday, in Abuja.

She said that the vaccine can be stored at 2 to 8-degree centigrade.

AstraZeneca vaccine was recently approved by the World Health Organisation, WHO.

The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine.

Recall there’s been some confusion over the efficacy of the AstraZeneca vaccine, because of a dosing mistake in one of the early trials. But what’s clear is that its efficacy with a standard, two-dose schedule is 62%.

Read Also: B117 Strain of COVID-19: Osun Records Five Cases

In another report, AZD1222 vaccine has an efficacy of 63.09% against symptomatic SARS-CoV-2 infection.

However, the NAFDAC boss said the body got the dossier of the vaccine a week ago and its safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

She said there are three additional vaccines undergoing evaluation, but the evaluation on Astrazeneca shows that the vaccine is effective against the UK variant of the virus which has been reported in Nigeria.

Dr Adeyeye disclosed that the South African variant has not been reported in Nigeria, adding that the agency has over 30 herbal medicine undergoing review for listing.

Leave a Reply